Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2020
Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients With Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup StudyViktor Grünwald, Annika Karch, Markus Schuler, et al.Cancer Research|May 24, 2018
Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell TransformationMarkus W Löffler, Daniel J Kowalewski, Linus Backert, et al.The Lancet. Oncology|May 25, 2019
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trialHoward West, Michael McCleod, Maen Hussein, et al.JAMA Oncology|December 23, 2020
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical TrialHans-Joachim Schmoll, Lars H Lindner, Peter Reichardt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 22, 2019
Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung CancerJulien Mazieres, Dariusz Kowalski, Alexander Luft, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 15, 2021
Outcomes With Pembrolizumab Plus Platinum-Based Chemotherapy for Patients With NSCLC and Stable Brain Metastases: Pooled Analysis of KEYNOTE-021, -189, and -407Steven F Powell, Delvys Rodríguez-Abreu, Corey J Langer, et al.Cell Stem Cell|March 7, 2009
Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cellsAndrea T Hooper, Jason M Butler, Daniel J Nolan, et al.Nature Communications|October 4, 2017
NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemiaMelanie Märklin, Jonas S Heitmann, Alexander R Fuchs, et al.Clinical Lung Cancer|June 29, 2026
Outcomes of Platinum Plus Pemetrexed and Treatment Patterns Following First-Line Nivolumab and Ipilimumab in Pleural Mesothelioma: Real-World Results From the German MesoNet StudyRajiv Shah, Eva L Buchmeier, Hans-Georg Kopp, et al.Therapeutic Advances in Medical Oncology|June 9, 2021
A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancerMartin Metzenmacher, Hans-Georg Kopp, Frank Griesinger, et al.Pageof 10